StockIQpro
NASDAQ:CYRX

Cryoport, Inc.

Cryoport, Inc.'s revenue grew 12.4% in fiscal 2025 to $176.2M while operating margin rose to −20.9%. Free cash flow was −$25.0M, −14.2% of revenue, and the diluted share count rose 1.5%.Summary generated from Cryoport, Inc.'s SEC filings. Latest annual report filed Mar 5, 2026.

Revenue (FY25)$176.2M
Revenue growth+12.4%
Revenue, 5-yr CAGR+17.5%
Gross margin47.1%
Operating margin−20.9%
Net margin44.4%
ROICn/a
Return on equity17.3%
Debt / equityn/a
Free cash flow−$25.0M
FCF margin−14.2%
Share count change+1.5%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue223237169157176
Operating income−18−32−101−122−37
Net income−276−37−100−11578
Free cash flow−16−24−40−34−25

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations